Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 2003Journal of Bone and Joint Surgery

Osteoporosis and Bisphosphonates☆

View Full Paper
Ask AI
Bookmark
Share

Authors

GRGideon A. RodanUniversity of BernARAlfred A. ReszkaMerck & Co., Inc., Rahway, NJ, USA (United States)

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Rodan et al. (2003) studied this question.

synapsesocial.com/papers/6a93802f41ef2b48b885aaeehttps://doi.org/10.2106/00004623-200300003-00003
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Genetic determinants of bone mass in adults. A twin study.1987 · 1,259 citations
  2. 2In VivoEffects of Bisphosphonates on the Osteoclast Mevalonate Pathway2000 · 151 citations
  3. 3Skeletal Benefits of Alendronate: 7-Year Treatment of Postmenopausal Osteoporotic Women12000 · 336 citations